This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Search results
From Proteopedia
You searched for Schiebel,_J.
There is no page with the exact title "Schiebel,_J.". The search results for "Schiebel,_J." are displayed below. You can create a page titled Schiebel,_J. (by clicking on the red link).
For more information about searching Proteopedia, see Help.
To exclude pages titled with 4-character PDB codes, use the checkbox "only Human created pages" at the bottom of this page.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Schiebel, J (42 bytes)
1: List of pages with the keyword Schiebel, J - Category:Schiebel J (41 bytes)
1: List of pages with the keyword Schiebel J
Page text matches
- 4bnl (4,243 bytes)
16: ...e S. aureus FabI enzyme-product complex.,Chang A, Schiebel J, Yu W, Bommineni GR, Pan P, Baxter MV, Khanna A...
33: [[Category: Schiebel J]] - 4bng (4,229 bytes)
16: ...e S. aureus FabI enzyme-product complex.,Chang A, Schiebel J, Yu W, Bommineni GR, Pan P, Baxter MV, Khanna A...
33: [[Category: Schiebel J]] - 8rzb (3,797 bytes)
16: ...ehr P, Meier P, Muller L, Ostermeier D, Ramage P, Schiebel-Haddad S, Smith AB, Stojanovic A, Velcicky J, Yam... - 8ryk (3,818 bytes)
16: ...ehr P, Meier P, Muller L, Ostermeier D, Ramage P, Schiebel-Haddad S, Smith AB, Stojanovic A, Velcicky J, Yam... - 4ali (3,582 bytes)
16: ... Potential Implications for In Vivo Essentiality.,Schiebel J, Chang A, Lu H, Baxter MV, Tonge PJ, Kisker C S...
32: [[Category: Schiebel J]] - 4alj (3,608 bytes)
16: ... Potential Implications for In Vivo Essentiality.,Schiebel J, Chang A, Lu H, Baxter MV, Tonge PJ, Kisker C S...
32: [[Category: Schiebel J]] - 4alk (3,606 bytes)
16: ... Potential Implications for In Vivo Essentiality.,Schiebel J, Chang A, Lu H, Baxter MV, Tonge PJ, Kisker C S...
32: [[Category: Schiebel J]] - 4all (3,532 bytes)
16: ... Potential Implications for In Vivo Essentiality.,Schiebel J, Chang A, Lu H, Baxter MV, Tonge PJ, Kisker C S...
32: [[Category: Schiebel J]] - 4alm (3,364 bytes)
16: ... Potential Implications for In Vivo Essentiality.,Schiebel J, Chang A, Lu H, Baxter MV, Tonge PJ, Kisker C S...
31: [[Category: Schiebel J]] - 4aln (3,194 bytes)
15: ... Potential Implications for In Vivo Essentiality.,Schiebel J, Chang A, Lu H, Baxter MV, Tonge PJ, Kisker C S...
30: [[Category: Schiebel J]] - 4bku (4,067 bytes)
16: ...linically Relevant Enoyl-ACP Reductase Inhibitor.,Schiebel J, Chang A, Shah S, Lu Y, Liu L, Pan P, Hirschbec... - 4bnm (4,248 bytes)
16: ...e S. aureus FabI enzyme-product complex.,Chang A, Schiebel J, Yu W, Bommineni GR, Pan P, Baxter MV, Khanna A...
33: [[Category: Schiebel J]] - 4bnh (4,228 bytes)
16: ...e S. aureus FabI enzyme-product complex.,Chang A, Schiebel J, Yu W, Bommineni GR, Pan P, Baxter MV, Khanna A...
33: [[Category: Schiebel J]] - 4bnj (4,229 bytes)
16: ...e S. aureus FabI enzyme-product complex.,Chang A, Schiebel J, Yu W, Bommineni GR, Pan P, Baxter MV, Khanna A...
33: [[Category: Schiebel J]] - 4c6u (3,852 bytes)
14: ... and Drug Target from Mycobacterium Tuberculosis.,Schiebel J, Kapilashrami K, Fekete A, Bommineni GR, Schaef...
34: [[Category: Schiebel J]] - 4c6v (3,817 bytes)
14: ... and Drug Target from Mycobacterium Tuberculosis.,Schiebel J, Kapilashrami K, Fekete A, Bommineni GR, Schaef...
34: [[Category: Schiebel J]] - 4c6w (3,926 bytes)
14: ... and Drug Target from Mycobacterium Tuberculosis.,Schiebel J, Kapilashrami K, Fekete A, Bommineni GR, Schaef...
34: [[Category: Schiebel J]] - 4c6x (3,963 bytes)
14: ... and Drug Target from Mycobacterium Tuberculosis.,Schiebel J, Kapilashrami K, Fekete A, Bommineni GR, Schaef...
34: [[Category: Schiebel J]] - 4c6z (3,924 bytes)
14: ... and Drug Target from Mycobacterium Tuberculosis.,Schiebel J, Kapilashrami K, Fekete A, Bommineni GR, Schaef...
34: [[Category: Schiebel J]] - 4c70 (3,979 bytes)
14: ... and Drug Target from Mycobacterium Tuberculosis.,Schiebel J, Kapilashrami K, Fekete A, Bommineni GR, Schaef...
34: [[Category: Schiebel J]]
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
